logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > China Stock

Harbin Hatou Investment (600864.SH) and its subsidiaries received a grant of 25.6684 million yuan.

date
24/09/2024
avatar
GMT Eight
Haotou Co., Ltd. (600864.SH) issued an announcement on September 23, 2024, that the company and its affiliated subsidiaries have received...
Harbin Hatou Investment (600864.SH) announced that on September 23, 2024, the company and its subsidiaries received government subsidies related to income of 25.6684 million yuan, accounting for 12.41% of the company's most recent audited consolidated net profit attributable to equity holders.
Related Articles
China Stock
Guangdong Taienkang Pharmaceutical (301263.SZ): The application for the registration and listing approval of sulfamethoxazole tablets has been accepted.
US Stock
SoftBank (SFTBY.US) and OpenAI's Japan AI joint venture plan has been reported to be delayed, with new developments expected to be announced in November.
Guotai Haitong: Initiates "buy" rating on BEST PACIFIC (02111) with a target price of HK$4.42.
Guangdong Taienkang Pharmaceutical (301263.SZ): The application for the registration and listing approval of sulfamethoxazole tablets has been accepted.
China Stock
SoftBank (SFTBY.US) and OpenAI's Japan AI joint venture plan has been reported to be delayed, with new developments expected to be announced in November.
US Stock
Guotai Haitong: Initiates "buy" rating on BEST PACIFIC (02111) with a target price of HK$4.42.
RECOMMEND
SAFE Enhances Convenience of Cross-Border Investment and Financing
SAFE Enhances Convenience of Cross-Border Investment and Financing
icon
16/09/2025
U.S. Moves to Expand Strategic Uranium Reserves as Nuclear Sector Stocks Rally
U.S. Moves to Expand Strategic Uranium Reserves as Nuclear Sector Stocks Rally
icon
16/09/2025
From Falling Orders to Surging Fertilizer Costs, U.S. Farmers Confront a “Trade and Fiscal Cliff”
From Falling Orders to Surging Fertilizer Costs, U.S. Farmers Confront a “Trade and Fiscal Cliff”
icon
16/09/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.